News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Dyax Corp. (DYAX) To Participate In The Jefferies and Co. Global Healthcare Conference


5/29/2014 7:54:44 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Dyax Corp. (NASDAQ: DYAX) announced today that executive management will participate in the Jefferies Global Healthcare Conference being held June 2-5, 2014 in New York City. Gustav Christensen, President and Chief Executive Officer of Dyax, will present on Monday, June 2 at 10:30 AM (ET). Mr. Christensen will provide a corporate update on the Company’s key value drivers – the KALBITOR® (ecallantide) business, DX-2930 and the LFRP.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES